참고문헌
- Asim M, Khan LA, Husain SA, et al (2010). Genetic polymorphism of glutathione S transferases M1 and T1 in Indian patients with hepatocellular carcinoma. Dis Markers, 28, 369-76. https://doi.org/10.1155/2010/328408
- Bian JC, Wang JB, Wu Y, et al (1996). Relationship between GSTM1 null genotype and genetic susceptibility to primary hepatocellular carcmoma. Chin J Med Genet, 13, 353-6 (in Chinese).
- Bian JC, Shen FM, Shen L, et al (2000). Susceptibility to hepatocellular carcinoma associated with null genotypes of GSTM1 and GSTT1. World J Gastroenterol, 6, 228-30.
- Chen SY, Wang LY, Lunn RM, et al (2002). Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer, 99, 14-21. https://doi.org/10.1002/ijc.10291
- Chen CC, Yang SY, Liu CJ, et al (2005). Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol, 34, 1310-8. https://doi.org/10.1093/ije/dyi191
- Chen YY, Ding F, Xie YA (2012). Study on gene polymorphisms of glutathione S-transferase GSTM1 and GSTT1 in high-risk families for liver cancer in Fusui county, Guangxi. Chin J Oncol Prev Treat, 4, 140-4.
- Chen J, Ma L, Peng NF, Wang SJ, Li LQ (2012). A meta-analysis of the relationship between glutathione S-transferases gene polymorphism and hepatocellular carcinoma in Asian population. Mol Biol Rep, 39, 10383-93. https://doi.org/10.1007/s11033-012-1917-0
- Dong CH, Yu SZ, Chen GC, et al (1997). Polymorphisms of GSTTl and M1 genotypes and their effects on elevated aflatoxin exposure and increased risk of hepatoeellular carcinoma. J Cancer Prev Treat, 24, 327-9 (in Chinese).
- Dong CH, Zi XL, Yu SZ, et al (1997). Relationship between deletion of glutathione S-transferase gene and susceptibility to primary hepatocellular carcinoma. Chin Pub Health J, 16, 141-2 (in Chinese).
- Deng ZL, Wei YP, Ma Y (2001). Glutathione-S-transferase M1 genotype in patients with hepatocellular carcinoma. Chin J Oncol, 23, 477-9 (in Chinese).
- Deng ZL, Wei YP, Ma Y (2005). Polymorphism of glutathione S-transferase mu 1 and theta 1 genes and hepatocellular carcinoma in southern Guangxi, China. World J Gastroenterol, 11, 272-4. https://doi.org/10.3748/wjg.v11.i2.272
- Deng ZL, Wei YP, Ma Y (2005). Genetic deletion of GSTM1 and GSTT1 detoxicated enzymes in relation to hepatocellular carcinoma in Guangxi. Guangxi Sci, 12, 55-7 (in Chinese).
- Guo HY, Bian JC, Jiang F, et al (2005). The null genotypes of GSTM1 and GSTT1 and the genetic susceptibility of primary liver cancer in Luoyang. Tumor, 25, 58-61 (in Chinese).
- Hu Y, Shen FM (1997). Association between GSTM1 gene polymorphism of primary hepatocellular carcinoma and mutation of p53 codon 249. Chin J Med Genet, 14, 76-8 (in Chinese).
- He SJ, Tan JR, Gu YY, et al (2005). Genetic polymorphism analysis of GSTM1, GSTT1 in patients with hepatocellular carcinoma. J Guangxi Med Univ, 22, 875-7 (in Chinese).
- Jeng JE, Tsai MF, Tsai HR, et al (2014). Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing. Asian Pac J Cancer Prev, 15, 637-42. https://doi.org/10.7314/APJCP.2014.15.2.637
- Kiran M, Chawla YK, Kaur J (2008). Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viralrelated hepatocellular carcinoma risk in India. DNA Cell Biol, 27, 687-94. https://doi.org/10.1089/dna.2008.0805
- Kao CC, Chen MK, Kuo WH, et al (2010). Influence of glutathione-S-transferase theta (GSTT1) and mu (GSTM1) gene polymorphisms on the susceptibility of hepatocellular carcinoma in Taiwan. J Stag Oncol, 102, 301-7.
- Liu CZ, Bian JC, Jiang F, et al (2002). Genetic polymorphism of glutathione S-transferase M1, T1, P1 on susceptibility hepatocellular carcinoma. China Publ Health, 18, 935-6 (in Chinese).
- Li SP, Wu JZ, Ding JH, et al (2004). Impact of genetic polymorphisms of glutathione S-transferase T1, M1 on the risk of primary hepatocellular carcinoma in alcohol drinkers. Pract J Cancer, 19, 229-32 (in Chinese).
- Long XD, Ma Y, Wei YP, et a; (2005). Study on the detoxication gene gstM1, gstT1 and susceptibility to aflatoxin B1-related hepatocellular carcinoma in guangxi. Chin J Epidemiol, 26, 777-81 (in Chinese).
- Long XD, Ma Y, Wei YP, et al (2006). The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population,China. Hepatol Res, 36, 48-55. https://doi.org/10.1016/j.hepres.2006.06.004
- Li CG, Zhao ZM, Hu MG, Liu R (2012). Predictive role of glutathione-S-transferase gene polymorphisms in risk and prognosis of hepatocellular carcinoma. Asian Pacific of Cancer Prev, 13, 3247-52. https://doi.org/10.7314/APJCP.2012.13.7.3247
- Liu K, Zhang L, Lin XL, et al (2013). Association of GST genetic polymorphisms with the susceptibility to hepatocellular carcinoma (HCC) in chinese population evaluated by an updated systematic meta-analysis. Plos One, 8, 57043. https://doi.org/10.1371/journal.pone.0057043
- Liu HZ, Peng J, Zheng F, Wang CH, Han MJ (2013). Lack of assocation of glutathione S-transferase T1 gene null and susceptibility to lung cancer in China: A meta-analysis. Asian Pac J Cancer Prev, 14, 7215-9 https://doi.org/10.7314/APJCP.2013.14.12.7215
- Lakkakula S, Maram R, Munirajan AK, et al (2013). Functional PstI/RsaI polymorphisms in the CYP2E1Gene among South Indian Populations. Asian Pac J Cancer Prev, 14, 179-82. https://doi.org/10.7314/APJCP.2013.14.1.179
- McGlynn KA, Hunter K, LeVoyer T, et al (2003). Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res, 63, 4594-601.
- Ma DL, Chen YX, Li Y, et al (2005). Glutathione-S-transferase M1 and T1 polymorphisms (deficiency) and susceptibility to liver cancer in hepatitis B surface antigen positive (HBsAg positive) population. Guangxi Med J, 27, 656-7 (in Chinese).
- Peng J, Liu HZ, Zhu YJ (2014). Null glutathione S-transferase T1 and M1 genotypes and oral cancer susceptibility in China and India--a meta-analysis. Asian Pac J Cancer Prev, 15, 287-90. https://doi.org/10.7314/APJCP.2014.15.1.287
- Sun CA, Wang LY, Chen CJ, et al (2001). Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Carcinogenesis, 22, 1289-94. https://doi.org/10.1093/carcin/22.8.1289
- Sarma MP, Asim M, Medhi S, Bharathi T, Kar P (2012). Hepatitis C virus related hepatocellular carcinoma: a case control study from India. J Med Virol, 84, 1009-17. https://doi.org/10.1002/jmv.23290
- Tang YT, Li XP, Liu TQ, et al (2012). A study of genetic polymorphisms of glutathione S-transferase in patients with hepatocellular carcinoma. Chin J Lab Diagn, 16, 660-1 (in Chinese).
- Wu HL, Chen MN, Liu PX, et al (2000). Relationship between GSTM1 gene polymorphism and genetic susceptibility to primary hepatocellular carcinoma. Pract J Cancer, 15, 463-5 (in Chinese).
- Wei YP, Ma Y, Deng ZL (2003). Genetic polymorphisms of glutathione-S-transferase M1 and T1 and the risk of hepatocellular carcinoma. Tumor, 23, 464-6 (in Chinese).
- Wei YP, Long XD, Liu ZG, et al (2010). Genetic polymorphism of glutathione-S.transferase M1 and T1 in hepatocellular carcinoma and nasopharyngeal carcinoma. J Cancer Prev Treat, 37, 1162-5 (in Chinese).
- Wang B, Huang G, Wang D, et al (2010). Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: Evidence from an updated meta-analysis. J Hepatology, 53, 508-18. https://doi.org/10.1016/j.jhep.2010.03.026
- Xiao KY, Li LQ, Peng MH, et al (2011). Gene polymorphisms of GSTM1 and GSTT1 in the clustering families of hepatocellular carcinoma. Chin J Oncol Prev Treat, 3, 287- 90 (in Chinese).
- Yu MW, Gladek-Yarborough A, Chiamprasert S, et al (1995). Cytochrome P450 2El and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109, 1266-73. https://doi.org/10.1016/0016-5085(95)90587-1
- Yu MW, Chiu YH, Chiang YC, et al (1999). Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol, 149, 621-9. https://doi.org/10.1093/oxfordjournals.aje.a009862
- Yang ZG, Xie YA, Kuang ZP, et al (2009). Relationship between genetic polymorphisms of glutathione-S-transferase M1, T1 genes and susceptibility to hepatocelhilar carcinoma in population of Fusui District of Guangxi Zhuang Autonomous Region. Chin J Cancer Prev Treat, 16, 970-3 (in Chinese).
- Yu L, Wang CY, Xi B, et al (2011). GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population. World J Gastroenterol, 17, 3248-56
- Zhu WC, Chen Q, Luo CL, et al (2001). Relationship study between gene polymorphism of CYP1A1, GSTM1 and genetic susceptibility of primary hepatocellar carcinoma. China J Cancer Prevt, 8, 572-4 (in Chinese).
- Zhu MH, Chen XH, Zhou LF (2005). Association of genetic polymorphisms in glutathione S-transfereses M1 with hepatitis B-related hepatoeellular carcinoma. J Zhejiang Univ (Med Sci), 34, 126-30 (in Chinese).
- Zhang YC, Deng CS, Zhu YQ (2005). Study on genetic polymorphisms of xenobiotica metabolizing enzymes in hepatitis B virus-associated hepatic diseases. J Wenzhou Med Coll, 35, 464-7 (in Chinese).
피인용 문헌
- Independent and Additive Interaction Between Tumor Necrosis Factor β +252 Polymorphisms and Chronic Hepatitis B and C Virus Infection on Risk and Prognosis of Hepatocellular Carcinoma: a Case-Control Study vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10209
- Glutathione S-transferase T1 and M1 null genotypes and Parkinson’s disease risk: evidence from an updated meta-analysis vol.36, pp.9, 2015, https://doi.org/10.1007/s10072-015-2159-4
- EHHM, a novel phenolic natural product from Livistona chinensis, induces autophagy-related apoptosis in hepatocellular carcinoma cells vol.12, pp.5, 2016, https://doi.org/10.3892/ol.2016.5178